Valuation: StimCell Energetics Inc.

Market Cap 31.07L 27.78L 25.7L 23.27L 43.56L 30Cr 44.27L 3.09Cr 1.22Cr 15Cr 1.17Cr 1.14Cr 49Cr P/E 2027 *
-7.35x
P/E 2028 * -
Enterprise Value 31.07L 27.78L 25.7L 23.27L 43.56L 30Cr 44.27L 3.09Cr 1.22Cr 15Cr 1.17Cr 1.14Cr 49Cr EV / Sales 2027 *
-
EV / Sales 2028 * 5.18x
Free-Float
28.33%
Yield 2027 *
-
Yield 2028 * -
1 week+31.74%
Current month+37.73%
1 month+37.73%
3 months+9.78%
6 months+2.71%
Current year-24.25%
1 week 0.15
Extreme 0.146964
0.3
1 month 0.15
Extreme 0.146964
0.3
Current year 0.15
Extreme 0.146964
0.48
1 year 0.15
Extreme 0.146964
0.48
3 years 0
Extreme 0.0015
3.42
5 years 0
Extreme 1.4E-5
13.97
10 years 0
Extreme 1.4E-5
25.35
Manager TitleAgeSince
Chief Executive Officer 56 12/12/2023
Director of Finance/CFO 48 24/11/2014
Director TitleAgeSince
Chairman 74 26/02/2024
Director/Board Member 62 08/06/2020
Director/Board Member 56 12/12/2023
Date Insider Type Main position Quantity % Market Cap. Importance
18/12/25 Sell

Director

16,667 0.0807%
17/03/25 Tax

Director

6,08,41,472 -
25/02/25 Buy 15,000 0.0757%
Change 5-day change 1-year change 3-year change Capi.($)
-.--%+31.74%-24.25%-43.10% 31.07L
+0.88%+1.18%+40.64%+74.91% 6.47TCr
-0.26%+6.91%+9.79%+77.36% 5.48TCr
+0.47%+3.52%+9.71%+100.95% 5.35TCr
-1.92%+2.86%+25.78%+48.30% 4.6TCr
-2.03%+0.05%+17.41%+123.30% 4.29TCr
-1.90%+0.17%+214.64%+816.42% 4.01TCr
-2.26%-2.06%+15.38%+45.14% 3.35TCr
+0.22%-4.77%+26.59%+0.55% 2.4TCr
+12.10%+16.60%+58.50%+46.15% 2.37TCr
Average +0.53%+2.00%+39.42%+129.00% 3.83TCr
Weighted average by Cap. +0.08%+2.59%+43.74%+149.66%

Financials

2027 *2028 *
Net sales - 6L 5L 5L 4L 8L 5.71Cr 9L 59.73L 23.63L 2.99Cr 22.52L 22.04L 9.45Cr
Net income -5L -5L -4L -4L -7L -4.85Cr -7L -50.77L -20.08L -2.54Cr -19.14L -18.73L -8.04Cr -
Net Debt - -
Projected Income Statement - Annual - StimCell Energetics Inc.
Logo StimCell Energetics Inc.
StimCell Energetics Inc. is a biotech company, which is focused on the discovery, development and commercialization of therapeutic and non-therapeutic products that enhance cellular function, promote general wellness and alleviate health complications including, but not limited to aging, insulin sensitivity, high blood pressure, neuropathy and kidney function. The Company's main focus is on continued research and development of its eBalance Technology and its eBalance Home System. eBalance is a non-invasive, fully automated microcurrent electrotherapy system administering pre-programmed algorithms through the epidermis at the touch of a button to help you gain optimal wellness and reduce pain. Its eBalance represents a monumental stride in the realm of medical technology designed to rejuvenate and re-energize the human body at a cellular level. The operation of eBalance is an intricate process of precision engineering and human biology.
Employees
1
Date Price Change Volume
22/26/22 $0.1470 -41.19% 1,035
21/26/21 $0.2499 +54.28% 200

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - StimCell Energetics Inc.
  1. Stock Market
  2. Stocks
  3. STME Stock